Key Takeaways
- • Alignd, a Cape Town-based, women-led South African healthcare startup founded in 2018, has secured an undisclosed investment from venture capital firm Knife Capital through its third fund, Knife Fund III.
- • The capital will be used to expand Alignd's value-based care programmes into maternity and kidney care.
- • Alignd's model shifts healthcare payment from treatment volumes to patient outcomes, aligning patients, providers and medical schemes.
- • Alignd's palliative care programme now reaches more than 3.3 million lives, supported by a network of over 500 providers and seven medical schemes including GEMS, Fedhealth and Bonitas.
Summary
Alignd, a South African healthcare startup founded in 2018 and led by CEO Dr Lungi Nyathi, has received an undisclosed investment from Knife Capital, according to the source report. The investment was made through Knife Fund III, the third fund raised by the venture capital firm. The company is headquartered in Cape Town and is described as women-led.
Alignd designs healthcare programmes intended to align the incentives of patients, medical providers and medical schemes. Rather than paying for volumes of treatment, the model rewards patient outcomes. The company initially concentrated on palliative care, building a network of more than 500 providers and partnering with seven medical schemes, including GEMS, Fedhealth and Bonitas.
The palliative care programme now reaches more than 3.3 million lives. Funding from Knife Capital will support expansion of the company's value-based care programmes into maternity and kidney care. The source material does not disclose the investment size or valuation.
Alignd designs healthcare programmes intended to align the incentives of patients, medical providers and medical schemes. Rather than paying for volumes of treatment, the model rewards patient outcomes. The company initially concentrated on palliative care, building a network of more than 500 providers and partnering with seven medical schemes, including GEMS, Fedhealth and Bonitas.
The palliative care programme now reaches more than 3.3 million lives. Funding from Knife Capital will support expansion of the company's value-based care programmes into maternity and kidney care. The source material does not disclose the investment size or valuation.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.